Loading clinical trials...
Loading clinical trials...
One of the leading causes of hip arthritis is developmental dysplasia of the hip (DDH). DDH can lead to major damage in the hip joint and may result in hip arthritis later in life. Patients recruited ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
NCT05869851 · Developmental Dysplasia of the Hip, Hip Dysplasia, and more
NCT03107520 · Developmental Dysplasia of the Hip
NCT04101903 · Developmental Dysplasia of the Hip
NCT07134036 · Osteoarthritis, Hip, Femur Head Necrosis, and more
NCT06747767 · Developmental Dysplasia of the Hip (DDH)
Ottawa Hospital - General Campus
Ottawa, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions